Biodesix GAAP EPS of -$0.08 misses by $0.02, revenue of $18M misses by $3.23M
Source: SeekingAlpha
2025-05-14 12:39:21 ET
More on Biodesix
- Biodesix, Inc. (BDSX) Q1 2025 Earnings Call Transcript
- Biodesix, Inc. (BDSX) Q4 2024 Earnings Call Transcript
- Biodesix revises 2025 revenue guidance to $80M–$85M amid sales force reconfiguration and primary care expansion
- Seeking Alpha’s Quant Rating on Biodesix
- Historical earnings data for Biodesix
Read the full article on Seeking Alpha
For further details see:
Biodesix GAAP EPS of -$0.08 misses by $0.02, revenue of $18M misses by $3.23M
Biodesix Inc.
NASDAQ: BDSX
BDSX Trading
-7.21% G/L:
$17.89 Last:
9,253 Volume:
$17.90 Open:
BDSX Latest News
February 26, 2026 04:01:00 pm
Biodesix Announces Fourth Quarter and Fiscal Year 2025 Results and Highlights
BDSX Stock Data
$83,296,022
3,850,552
19.65%
10
N/A
Medical Diagnostics & Screening
Healthcare
US
Louisville
